Indegene has been selected as an Official Honoree at the 2010 edition of The Webby Awards (Pharmaceuticals Category) for the Virtual Oncology Center (VOC) developed for a top pharmaceutical company. The Official Honoree distinction is awarded to the top 15% of all work entered. The Webbys, this year received over 10,000 entries from all 50 states and over 60 countries.

Dr.Rajesh Nair, President and CEO, Indegene Inc. said, “The overall vision was to redesign how a product and the brand it represents can engage with oncologists and other health care stakeholders in a meaningful and sustainable manner. The changes in the marketplace represent a fundamental opportunity for companies to build new multichannel promotional and educational models and develop new ways of doing business”

The VOC offers health care providers an innovative and unique online platform for medical education and communication. The center provides highly interactive patient cases, KOL videos, learning modules, Webcasts as well as a deep repository of product information, clinical content, and reference materials.

Explaining Indegene’s unique global delivery model, Dr. Nair said, “In today’s world where companies are trying to reduce the overall marketing and sales spends, a global delivery model provides the first viable model for marketing and brand teams to generate “more with less,” encouraging innovation and promotional leadership while enhancing quality, service levels, and share of voice.”
 

The Webby Awards is the leading international award honoring excellence on the Internet. Established in 1996 during the Web's infancy, the Webbys are presented by The International Academy of Digital Arts and Sciences, which includes an Executive 750-member body of leading Web experts, business figures, luminaries, visionaries and creative celebrities, and Associate Members who are former Webby Award Winners and Nominees and other Internet professionals.

The Official Honoree listing can be found here http://www.webbyawards.com/webbys/current_honorees.php

November 4, 2009
Pennsylvania and London

The pharmaceutical industry relies heavily on the sales and marketing functions to maximize organizational returns. Over the last few years, the existing sales and marketing models, especially in developed markets, have been under tremendous pressure due to factors such as

• Absence of blockbusters
• Patent expiries and competition from generics
• Stricter regulatory environment
• Changing customer/market dynamics
• Challenges in managed care and reimbursement

The last 10 years have seen a seismic shift in the dynamics of pharmaceutical sales and marketing. The return on investment in sales force expansion is shrinking, causing almost all major pharmaceutical companies to reduce their head counts. Furthermore, it is increasingly evident that the market and regulators are interested in new therapies that address an unmet need rather than yet another product in an existing class of molecules with little or no clinical or economic benefit.

In this paper, Manish Gupta, Director, Indegene Lifesystems, and Rajesh Nair, President and CEO, Indegene Inc., discuss how pharmaceutical companies, as part of their restructured sales and marketing partnership model, can leverage the advantages of offshore deliveries to ensure sales and marketing effectiveness and meet reduced budget targets, while maintaining existing levels of service quality and efficiency.

This whitepaper will help you understand

• The new Market Realities and how they call for New Operating Models in sales and marketing.
• The Benefits of offshoring derived by the strategic marketing, commercialization, brand management, product management and sales training teams. These benefits go much beyond a pure cost model, enabling pharma companies to compete more effectively in the marketplace.
• The various global models and the benefits each offer, elucidated by case studies.

PharmaLive http://whitepapers.pharmalive.com/

Scrip News http://www.scripnews.com/whitepapers/

October 26, 2009 Texas
Indegene has won 4 awards in the following categories:

Web Site Overall
Web Interactive Capabilities

Design/Web Site Interior
Design/Web Site

The award-winning entry was a part of the work done for one of the largest companies in the pharmaceutical industry. The entry was an innovative virtual center for medical communications that offers health care providers a unique and interactive educational experience. The center provides online education to supplement off-line educational activities through interactive patient cases, key opinion leader (KOL) videos, learning modules, etc.
The ability and the opportunity to integrate traditional channels like the sales force and direct marketing with new and exciting online and electronic channels was the driving force behind the design and development of this revolutionary virtual center. The overall vision was to redesign how a product and the brand it represents can engage with physicians and other health care stakeholders in a meaningful and sustainable manner.  

MarCom Awards is an international competition for marketing and communication professionals involved in the concept, writing, and design of marketing and communication programs, and print, visual, and audio materials. Entries come from corporate marketing and communication departments, advertising agencies, PR firms, design shops, production companies, and freelancers.
The competition has grown to perhaps the largest of its kind in the world. A look at the winners shows a range in size from individual communicators to media conglomerates and Fortune 50 companies. The competition is so well thought of in the industry that national public relations organizations, local ad clubs, and local business communicator chapters are entrants.  

To know more about our winning entries, write to bd@indegene.com

September 29, 2009
New Jersey
Indegene has won 3 awards of excellence in the following categories:

Flash interactive modules or kiosks
Training tools
Training Web site

The award winning entries were a part of the work done for two of the largest companies in the pharmaceutical industry. The entry for “Training Web site” was an innovative virtual center for medical communications which offers health care providers a unique and interactive educational experience. The center provides online education to supplement off-line educational activities through interactive patient cases, KOL videos, learning modules, etc.

The entry for “Flash interactive modules or kiosks” and “Training tools” was a training program replete with high-end flash animations and 3D graphics which made it a highly engaging tool.
About the Rx Club Award

Founded in 1986 by Ina and Carveth Kramer, The RX Club Show continues to honor the creative aspects of pharmaceutical product advertising and promotion. The show is judged in various categories by a panel of industry experts and is based solely on creativity. Creative concept and execution remain the only criteria for merit - not media buy or budget - simply creativity.

To know more about our winning entries, write to bd@indegene.com

September 13, 2009
New York

Abstract

Over the last few years, most of the innovations in pharmaceutical development have been only incremental — for most indications, there are significant therapy options available and it is unlikely that a radically better “wonder drug” will become available soon. In this white paper, Sanjay Parikh, PhD, Director, Indegene Lifesystems, discusses the essence of “claims-based R&D” that lies in taking a backward “market to lab” approach so as to ensure that the CDP is designed to address specific unmet market needs. It also involves the systematic benchmarking of a product’s CDP to current and future competition while continuously evaluating scientific and market threats and opportunities.

This white paper will help you understand

• How consumer, scientific and competitor insights can be used to align pharmaceutical R&D to the unmet needs of the market.
• The role of a robust clinical development plan and clinical operations plan in achieving a TPP, superior to that of the competitor.
• How “claims-based R&D” can be incorporated in an organization’s strategic framework at significantly reduced costs

Click on the link below to view the white paper

http://www.fiercebiotech.com/whitepapers/competitive-benchmarking-cdps-optimize-trial-designs-and-clinical-operations
 

June 21, 2009
San Diego

DIA (Drug Information Association) is a premier global information source for the biopharmaceutical community and is committed to exceeding the professional development needs of the community it serve.

DIA meetings and conferences highlight hot topics in more than 25 interest areas. DIA’s premier North American event, the Annual Meeting, is the largest and most-respected industry event of its kind.

Click on the link below to know more about DIA http://www.diahome.org/DIAHome/Home.aspx